Skip to content

Ayurvedic treatment for migraine

EFFICACY OF MUNDI SWARASA IN THE MANAGEMENT OF ARDHAVABHEDAKA W.S.R. TO MIGRAINE - A RANDOMIZED CONTROLLED CLINICAL TRIAL - MSABMG

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/037839
Enrollment
30
Registered
2021-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

None listed

Sponsors

Dr Nancy Jeyaseeli A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with classical symptoms of ardhavabhedaka and ICHD criteria for migraine without aura

Exclusion criteria

Exclusion criteria: Patients suffering from secondary headache due to meningitis,tumour,encephalitis,sinusitis and glaucoma Pregnancy and lactation Patients having migraine other than migraine without aura Patients with diabetes,TB,hypertension and any other systemic disorders

Design outcomes

Primary

MeasureTime frame
The trial drug may be effective in managing symptoms of migraineTimepoint: 7 days

Secondary

MeasureTime frame
The trial drug may be effective in reducing severity of migraine symptomsTimepoint: 7 days

Countries

India

Contacts

Public ContactDr KS Sangolli

KAHERs Shri BM Kankanwadi Ayurveda Mahavidyalaya

drksskle@gmail.com9448266969

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026